Skip to content
PubMed This is a summary of 20 peer-reviewed journal articles Updated
Cardiology · Heart Failure

Which OTC Drugs and Supplements Are Unsafe in Heart Failure?

At a Glance

With heart failure, check with a pharmacist or clinician before using any OTC medicine or supplement. NSAIDs, oral decongestants, high-sodium products, potassium supplements, licorice, laxatives, and weight-loss products can worsen fluid balance, blood pressure, kidney function, or heart rhythm.

Many over-the-counter (OTC) medicines, cold remedies, and dietary supplements can interact with congestive heart failure treatments or worsen symptoms. For example, some nonsteroidal anti-inflammatory drugs (NSAIDs) and oral decongestants can promote fluid retention, increase blood pressure, or put extra strain on the heart [1][2]. Because heart failure management relies on a careful balance of fluids, electrolytes, and medications, it is important to check with a pharmacist or doctor before starting any new product to avoid unintended complications [3].

Why Pain Relievers Like NSAIDs Require Caution

NSAIDs (nonsteroidal anti-inflammatory drugs), such as over-the-counter ibuprofen and naproxen, are commonly used for pain and fever, but they should generally be avoided if you have heart failure [4]. These drugs work by blocking the production of prostaglandins—chemicals in the body that normally help keep blood vessels relaxed and support kidney function [1].

When prostaglandin production is blocked, it can cause the body to hold onto sodium and water [1]. This fluid retention can quickly lead to swelling (edema) and worsen heart failure symptoms [1]. NSAIDs can also blunt the effectiveness of your diuretics (water pills) [4]. If you take an analgesic-dose NSAID alongside common heart failure medications—like a diuretic and an ACE inhibitor, ARB, or ARNI—you are at a particularly high risk for acute kidney injury (a sudden drop in kidney function), a combination sometimes called the “triple whammy” [5]. This risk is even higher if you are dehydrated or have existing kidney impairment [5].

Note: If your doctor has prescribed low-dose aspirin for a cardiovascular condition, do not stop taking it without their advice. While aspirin is technically an NSAID, clinician-directed low-dose aspirin is used differently than higher-dose pain relievers.

The Danger of Stimulant Decongestants

When you have a cold or allergies, oral decongestants containing pseudoephedrine or phenylephrine might seem helpful, but they can be problematic for heart failure patients. These drugs are sympathomimetics (stimulants) that constrict blood vessels [6]. This increases vascular resistance, forcing your heart to pump against higher pressure [6]. As a result, these decongestants may raise your blood pressure or cause heart-rate changes, putting unnecessary stress on the heart [2]. Additionally, oral phenylephrine has very limited evidence of actually improving nasal congestion [7].

Topical nasal decongestant sprays (like oxymetazoline or xylometazoline) work locally and rapidly improve congestion, but they can still have cardiovascular effects and can cause severe rebound congestion if used longer than the recommended few days [8][9]. Always ask a pharmacist for safer alternatives for persistent congestion.

Beware of Combination Cold and Flu Products

One of the biggest hazards in the drugstore aisle is the combination product. Multi-symptom cold, flu, and allergy medicines frequently bundle several active ingredients together [10]. A single product might contain an antihistamine, a decongestant, and a pain reliever [11].

You must always read the active ingredient labels carefully [12]. The goal is to avoid unintentionally taking decongestants, hidden sodium, or duplicate doses of medicines (such as taking acetaminophen for a headache while also drinking a cold syrup that contains acetaminophen) [10].

Supplements and Medicines to Review with a Pharmacist

Before buying any new over-the-counter product, consult your pharmacist to check for interactions with your specific heart failure medicines. You do not have to memorize every risk—just show the package to the pharmacist. Pay special attention to:

  • Antacids: Some effervescent (fizzing) antacids contain high amounts of sodium, which can trigger fluid retention. Other antacids contain magnesium or aluminum, which can accumulate in your body if you have underlying kidney disease [13]. Antacids can also interfere with the absorption of your prescription medicines.
  • Laxatives: Frequent use of laxatives, or specific types like sodium-phosphate and magnesium products, can cause diarrhea and significant loss of fluids [14]. When combined with prescription diuretics, this can dangerously deplete your electrolytes and worsen kidney function [15].
  • Potassium Products and Salt Substitutes: While some diuretics lower potassium, other heart failure medications (like ACE inhibitors, ARBs, ARNIs, and spironolactone) cause your body to hold onto potassium [16]. Taking OTC potassium supplements or using potassium-based salt substitutes can push your levels too high (hyperkalemia), which can cause dangerous heart rhythms [17]. Do not start or stop prescribed potassium without your prescriber’s direction.
  • Licorice: Natural black licorice or licorice root supplements contain glycyrrhizin. This compound can cause pseudoaldosteronism, leading to severe potassium loss and increased blood pressure; in rare reported cases, it has even triggered pulmonary edema (fluid in the lungs) and temporary worsening of heart function [18].
  • Weight-Loss Products: Dietary supplements are regulated differently than prescription drugs and are not pre-approved for safety or effectiveness. Many OTC weight-loss supplements contain sympathomimetics (stimulants) that can increase heart rate and blood pressure, exacerbating the harmful sympathetic nervous system activation already present in heart failure [19].

Is Acetaminophen Safe?

Patients are often told to use acetaminophen (Tylenol) as an alternative to NSAIDs for mild pain because it does not cause the same fluid retention or kidney risk [20]. However, it is not universally safe.

Acetaminophen must be carefully dosed, and you must count the acetaminophen from every combination product you take to avoid exceeding your daily limit. If you have liver disease or drink alcohol regularly, your safe limit is lower. Additionally, regular or higher-dose use of acetaminophen can interact with the anticoagulant (blood thinner) warfarin. Some large observational studies have observed slightly higher rates of cardiovascular events with acetaminophen compared to no treatment, though the evidence is complex and it is generally considered safer than NSAIDs for heart failure [20]. Always ask your doctor for your personal maximum daily dose.

When to Seek Help

If you have taken a new OTC product and develop new or worsening shortness of breath, rapidly increasing swelling or weight, severe dizziness, chest pain, new sustained palpitations, or markedly reduced urination, contact your care team or seek emergency care immediately. Do not adjust your prescribed diuretics or fluid limits on your own to compensate.

Common questions in this guide

Which pain relievers should I avoid if I have heart failure?
Over-the-counter NSAIDs such as ibuprofen and naproxen are generally best avoided because they can make the body retain sodium and water, reduce the effect of water pills, and increase kidney injury risk. Do not stop prescribed low-dose aspirin without asking the clinician who recommended it.
Can I take pseudoephedrine or phenylephrine for a cold with heart failure?
Oral pseudoephedrine and phenylephrine can narrow blood vessels and may raise blood pressure or change heart rate, adding strain to the heart. Nasal sprays such as oxymetazoline can also have cardiovascular effects and should be used only as directed; ask a pharmacist about alternatives.
Is acetaminophen a safe pain reliever for people with heart failure?
Acetaminophen is often considered safer than NSAIDs for mild pain because it does not cause the same fluid retention or kidney risk, but it still must be dosed carefully. Count acetaminophen in every combination product, and ask your clinician about a lower limit if you have liver disease, regularly drink alcohol, or take warfarin.
Should I use potassium supplements or potassium-based salt substitutes?
Only use them if your prescriber tells you to. ACE inhibitors, ARBs, ARNIs, and spironolactone can raise potassium, so adding an OTC supplement or potassium-based salt substitute may cause dangerously high levels and abnormal heart rhythms.
Which other OTC products and supplements need extra caution with heart failure?
Effervescent antacids may contain enough sodium to promote fluid retention, while magnesium or aluminum products can build up when kidney function is reduced. Frequent or certain laxatives, licorice, and stimulant weight-loss supplements can disturb fluids, electrolytes, blood pressure, or heart rate, so review them with a pharmacist.
When should I get help after taking an OTC product?
Seek emergency care or contact your care team immediately for new or worsening shortness of breath, rapidly increasing swelling or weight, chest pain, sustained palpitations, severe dizziness, or much less urination. Do not change your prescribed diuretic dose or fluid limit on your own.

Get notified when new evidence is published on congestive heart failure.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (20)
  1. 1

    Prevention of Renal Complications Induced by Non- Steroidal Anti-Inflammatory Drugs.

    Ković SV, Vujović KS, Srebro D, et al.

    Current medicinal chemistry 2016; (23(19)):1953-64 doi:10.2174/0929867323666160210125920.

    PMID: 26861001
  2. 2

    Effect of adrenergic agonist oral decongestants on blood pressure.

    Chan JJ, Chan M, Wright JM

    The Cochrane database of systematic reviews 2025; (3()):CD007895 doi:10.1002/14651858.CD007895.pub3.

    PMID: 40145549
  3. 3

    Non-steroidal anti-inflammatory drugs and risk of heart failure exacerbation: A systematic review and meta-analysis.

    Ungprasert P, Srivali N, Kittanamongkolchai W

    European journal of internal medicine 2015; (26(9)):685-90.

    PMID: 26427540
  4. 4

    Frequency and Associations of Prescription Nonsteroidal Anti-inflammatory Drug Use Among Patients With a Musculoskeletal Disorder and Hypertension, Heart Failure, or Chronic Kidney Disease.

    Bouck Z, Mecredy GC, Ivers NM, et al.

    JAMA internal medicine 2018; (178(11)):1516-1525 doi:10.1001/jamainternmed.2018.4273.

    PMID: 30304456
  5. 5

    Frequency and Profiles of Drug Combinations Constituting the Triple Whammy in Japan: An Analysis of a Patient Estimation Database.

    Maese M, Ito N, Shiokawa H, et al.

    Pharmacy (Basel, Switzerland) 2026; (14(5)) doi:10.3390/pharmacy14050117.

    PMID: 42646348
  6. 6

    Differential effects of phenylephrine on brain versus skeletal muscle microvascular perfusion: an in vivo laboratory study using translational rodent models.

    Jiang H, Chin K, Mak TH, et al.

    Canadian journal of anaesthesia = Journal canadien d'anesthesie 2026; (73(3)):282-296 doi:10.1007/s12630-026-03101-x.

    PMID: 42032394
  7. 7

    Nonprescription medications for respiratory symptoms: Facts and marketing fictions.

    Weinberger M, Hendeles L

    Allergy and asthma proceedings 2018; (39(3)):169-176 doi:10.2500/aap.2018.39.4117.

    PMID: 29669663
  8. 8

    Revisiting Rhinitis Medicamentosa: Examining the Evidence on Topical Nasal Decongestants.

    Hagen M, Varbiro G, Montanari E, Ballerini Fernandes M

    Journal of pharmacy practice 2026; (39(2)):117-139 doi:10.1177/08971900251350510.

    PMID: 40580050
  9. 9

    Part II - imidazolines and rhinitis medicamentosa: how can we tackle the rebound dilemma?

    Stinson RJ, Sadofsky LR

    Frontiers in pharmacology 2025; (16()):1655254 doi:10.3389/fphar.2025.1655254.

    PMID: 41394157
  10. 10

    Effect of fexofenadine/pseudoephedrine combination tablet on nasal obstruction in patients with allergic rhinitis using rhinomanometry: A randomized controlled trial.

    Nakamura Y, Yokoyama Y, Koyama S, et al.

    Asian Pacific journal of allergy and immunology 2024; (42(2)):147-153 doi:10.12932/AP-160920-0963.

    PMID: 33638625
  11. 11

    Acute Ischemic Colitis due to Oral Phenylephrine.

    El-Alali E, Alhmoud T

    ACG case reports journal 2020; (7(9)):e00459 doi:10.14309/crj.0000000000000459.

    PMID: 33062792
  12. 12

    Redundancy of Pharmacologic Ingredients in Over-the-Counter Nasal Sprays.

    Trinh LN, Smith DK, McCoul ED

    OTO open 2024; (8(4)):e70022 doi:10.1002/oto2.70022.

    PMID: 39354953
  13. 13

    Management of hyperkalaemia in acute kidney injury in a heart failure patient with patiromer.

    Slawik J, Dederer J, Kindermann I, Böhm M

    ESC heart failure 2020; (7(5)):3161-3164 doi:10.1002/ehf2.12711.

    PMID: 32840030
  14. 14

    Hyponatremia in acute decompensated heart failure: depletion versus dilution.

    Verbrugge FH, Steels P, Grieten L, et al.

    Journal of the American College of Cardiology 2015; (65(5)):480-92.

    PMID: 25660927
  15. 15

    Acid-base and electrolyte abnormalities in heart failure: pathophysiology and implications.

    Urso C, Brucculeri S, Caimi G

    Heart failure reviews 2015; (20(4)):493-503 doi:10.1007/s10741-015-9482-y.

    PMID: 25820346
  16. 16

    Barriers to guideline mandated renin-angiotensin inhibitor use: focus on hyperkalaemia.

    Vijayakumar S, Butler J, Bakris GL

    European heart journal supplements : journal of the European Society of Cardiology 2019; (21(Suppl A)):A20-A27 doi:10.1093/eurheartj/suy030.

    PMID: 30837801
  17. 17

    Serum potassium and clinical outcomes in heart failure patients: results of risk calculations in 21 334 patients in the UK.

    Linde C, Qin L, Bakhai A, et al.

    ESC heart failure 2019; (6(2)):280-290 doi:10.1002/ehf2.12402.

    PMID: 30629342
  18. 18

    Dramatic recovery of left ventricular dysfunction in a patient with pseudoaldosteronism, hypokalaemia, and rhabdomyolysis: a case report.

    Ito S, Hasebe M, Inoko M

    European heart journal. Case reports 2023; (7(9)):ytad398 doi:10.1093/ehjcr/ytad398.

    PMID: 37662578
  19. 19

    Sympathetic activation in congestive heart failure: an updated overview.

    Grassi G, Quarti-Trevano F, Esler MD

    Heart failure reviews 2021; (26(1)):173-182 doi:10.1007/s10741-019-09901-2.

    PMID: 31832833
  20. 20

    Diclofenac use and cardiovascular risks: series of nationwide cohort studies.

    Schmidt M, Sørensen HT, Pedersen L

    BMJ (Clinical research ed.) 2018; (362()):k3426 doi:10.1136/bmj.k3426.

    PMID: 30181258

This page is for informational purposes only and does not constitute medical advice. Ask your prescriber or pharmacist to review every new OTC medicine or supplement alongside your heart failure medicines and other health conditions.